Patent 9815864 was granted and assigned to Alios BioPharma, Inc. on November, 2017 by the United States Patent and Trademark Office.
Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same, of the Formula (I).